Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery.
about
Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regenerationThe physiology of cardiovascular disease and innovative liposomal platforms for therapyDynamic imaging of arginine-rich heart-targeted vehicles in a mouse model.Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects.Integrin targeted delivery of chemotherapeuticsHitting multiple targets with multimeric ligands.Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis.Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.Integrin targeted drug and gene delivery.Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.Liposome technology for cardiovascular disease treatment and diagnosis.Liposomes in biosensors.Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy.Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity.Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo.In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.[Pyr1]-Apelin-13 delivery via nano-liposomal encapsulation attenuates pressure overload-induced cardiac dysfunction.Optimization of RGD-modified Nano-liposomes Encapsulating Eptifibatide.A biomimetic peptide fluorosurfactant polymer for endothelialization of ePTFE with limited platelet adhesion.Interactions of heparin with human skin cells: binding, location, and transdermal penetration.Liposomes for the delivery of streptokinase.Antibody-targeted drug delivery to injured arteries using layered double hydroxide nanoparticles.Encapsulation of eptifibatide in RGD-modified nanoliposomes improves platelet aggregation inhibitory activity.Integrin Targeting and Toxicological Assessment of Peptide-Conjugated Liposome Delivery Systems to Activated Endothelial Cells.Pre-coating layered double hydroxide nanoparticles with albumin to improve colloidal stability and cellular uptakeAntimicrobial peptide-loaded liquid crystalline precursor bioadhesive system for the prevention of dental caries.Generation of Well-Defined Micro/Nanoparticles via Advanced Manufacturing Techniques for Therapeutic Delivery.Targeted delivery of thrombolytic agents: role of integrin receptorsPeptide KSL-W-Loaded Mucoadhesive Liquid Crystalline Vehicle as an Alternative Treatment for Multispecies Oral BiofilmTargeted Treatments for Restenosis and Vein Graft Disease
P2860
Q26765166-1FF61FE2-581C-4265-8854-3773C4A2189FQ27002949-D6C1E9C2-D423-4B27-8EB6-35FCE82E14BDQ30482759-7063D54B-61C5-4C79-8907-317DE7ECFBB3Q34144898-D9BD724D-E053-4BEA-BB94-93C242C6B3D4Q34912725-4F1CBA38-56A9-498E-8102-C859B791F19BQ35976363-3FFA1230-B3E2-4982-B028-F6B4D80BADAFQ36440766-DA530B08-5B77-431E-BEE5-1F72C1D4FD31Q36598388-64B2EBBA-74FF-48B0-A463-556B1E22ED87Q37572760-6780C05A-08D9-42D5-A70E-45FEBB599F3DQ37679945-434AD7BA-F54D-4003-8100-61DE577B3C90Q37938830-58247113-5590-4974-B1CE-288E356CF02BQ37974931-E55D485F-808F-4AB4-AD2D-81866C203318Q38052650-87B0DFE6-7613-4B07-AFF1-6B16A74B9792Q38527633-DD657BD0-122A-4289-8274-D294904C4E92Q39136593-8C51EEA9-0007-4FC5-A670-B43BEC2B6EFBQ39303502-A0F6A530-E6C8-45D7-A808-81ED0C5273AEQ40025769-12DBA9F5-4899-43B6-9514-161676C5D396Q41383344-C0CD54D2-B1DA-4D79-A9C4-71B379AF9661Q41674171-1905D8AE-AE21-4816-8106-8CE62230605AQ42591271-70E36285-AC83-4067-9F02-D88CE145CD24Q44623520-DC4C959D-91F2-4E9B-BB22-02E81CDB1D25Q49853329-B94CFF7D-9A4B-4566-A733-9C6B3466CB6FQ50487524-24E4AB08-FC66-4897-B2AB-C21A3413565BQ51124774-7FC66A09-6DCA-4D9C-B836-BF5FD9260016Q51130308-CE1CAF91-0F56-4A51-A467-75D4A26E9B8DQ54677886-355A75CF-7138-4597-885F-051374DC0438Q54974500-03F3D02B-10C2-467A-908A-7B8F043EF099Q54994812-F5F73117-921A-47A5-9F59-76CC9BDBB965Q56897486-4DF3CEE7-8468-44C2-8AA9-8823F62A9F67Q57383027-70F101A5-9196-414C-8D32-88D244A295D9Q58691736-E04230FE-2965-4147-A67C-9DD9CD0EE5AB
P2860
Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Surface modification of liposo ...... cardiovascular drug delivery.
@en
type
label
Surface modification of liposo ...... cardiovascular drug delivery.
@en
prefLabel
Surface modification of liposo ...... cardiovascular drug delivery.
@en
P2093
P1476
Surface modification of liposo ...... cardiovascular drug delivery.
@en
P2093
Aubrey J Case
Brian J Lestini
James M Anderson
Johnsamuel Jayaseharan
Matthew S Shive
Nancy J Richter
Roger E Marchant
Sharon M Sagnella
P304
P356
10.1016/S0168-3659(01)00505-3
P407
P577
2002-01-01T00:00:00Z